Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo

door Shammas, MA, Koley, H, Bertheau, RC, Neri, P, Fulciniti, M, Tassone, P, Blotta, S, Protopopov, A, Mitsiades, C, Batchu, RB, Anderson, KC, Chin, A, Gryaznov, S, Munshi, NC
Gepubliceerd in 2008

miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth

door Fulciniti, M, Amodio, N, Bandi, R L, Cagnetta, A, Samur, M K, Acharya, C, Prabhala, R, D'Aquila, P, Bellizzi, D, Passarino, G, Adamia, S, Neri, A, Hunter, Z R, Treon, S P, Anderson, K C, Tassone, P, Munshi, N C
Gepubliceerd in Blood Cancer J (2016)

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

door Szalat, R, Samur, M K, Fulciniti, M, Lopez, M, Nanjappa, P, Cleynen, A, Wen, K, Kumar, S, Perini, T, Calkins, A S, Reznichenko, E, Chauhan, D, Tai, Y-T, Shammas, M A, Anderson, K C, Fermand, J-P, Arnulf, B, Avet-Loiseau, H, Lazaro, J-B, Munshi, N C
Gepubliceerd in Leukemia (2018)

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

door Amodio, N, Di Martino, M T, Foresta, U, Leone, E, Lionetti, M, Leotta, M, Gullà, A M, Pitari, M R, Conforti, F, Rossi, M, Agosti, V, Fulciniti, M, Misso, G, Morabito, F, Ferrarini, M, Neri, A, Caraglia, M, Munshi, N C, Anderson, K C, Tagliaferri, P, Tassone, P
Gepubliceerd in 2012